We have located links that may give you full text access.
Schedules of Controlled Substances: Placement of Furanyl Fentanyl, 4- Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl fentanyl, and Ocfentanil in Schedule I. Final order.
Federal Register 2018 November 30
With the issuance of this final order, the Acting Administrator of the Drug Enforcement Administration maintains the placement of the substances furanyl fentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylfuran- 2-carboxamide], 4- fluoroisobutyryl fentanyl or parafluoroisobutyryl fentanyl [N-(4- fluorophenyl)-N-(1-phenethylpiperidin- 4-yl)isobutyramide], acryl fentanyl or acryloylfentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylacrylamide], tetrahydrofuranyl fentanyl [N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran-2- carboxamide], and ocfentanil [N-(2- fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4-yl)acetamide], including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, furanyl fentanyl, 4- fluoroisobutyryl fentanyl, acryl fentanyl, tetrahydrofuranyl fentanyl, and ocfentanil.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app